Shreya B. Kishore

Shreya B. Kishore

Auto-generated profile, based on publicly available information

Shreya B. Kishore

Faculty of Health, Medicine and Behavioural Sciences University of Queensland Brisbane Queensland Australia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2025 in Diabetic Medicine
Verified
Journal Article
Open access
SAShazhan Amed
Shazhan Amed
JBJeffrey N. Bone
Jeffrey N. Bone
SKShreya B. Kishore
Shreya B. Kishore
QZQian Zhang
Qian Zhang
JLJoseph Leung
Joseph Leung
Aims: Our study described incidence and prevalence trends of type 1 diabetes in children and youth under 20 years of age from 1997 to 2023 in the Canadian province of British Columbia (BC) and assessed for a 4‐, 5‐, or 6‐year cyclicity or increase in incidence during the COVID‐19 pandemic. Methods: Using linked population‐level databases and a validated case‐finding and diabetes differentiating algorithm, we identified children with type 1 diabetes diagnosed between 1997 and 2023. Data sources included hospital admissions, outpatient physician visits, and dispensed prescriptions. Population denominators were based on annual age‐ and sex‐stratified population estimates. We calculated incidence per 100,000 and prevalence per 100 cases, using JoinPoint regression to identify trend changes. Cyclical patterns were tested using sine and cosine terms. Results: From 1997 to 2023, the incidence of paediatric type 1 diabetes increased markedly until 2008 and then declined very gradually, with similar patterns across age and sex. Incidence was higher in boys, highest among children aged 5 to 14 years, and lowest in those aged 15 to 19 years. After 2012, prevalent cases stabilized in those under 10 and decreased in those over 10 years old. There was no evidence of cyclical trends or changes in incidence or prevalence during or after the COVID‐19 pandemic. Conclusions/Interpretation: We report a stabilization of type 1 diabetes incidence and prevalence, along with the absence of pandemic‐related increases. These trends may in part reflect demographic changes in British Columbia's paediatric population, including a growing proportion of children from immigrant backgrounds with historically lower type 1 diabetes risk. Unfortunately, our data sources do not include ethnicity, limiting our ability to explore these patterns directly. This study will support the optimization of resource allocation and inform healthcare improvement and long‐term management of childhood type 1 diabetes.

13 June 2022 in Pediatric Transplantation
Verified
Journal Article
Closed access
SBShreya Bhushan
Shreya Bhushan
CNCharlton Noble
Charlton Noble
FBFariha Balouch
Fariha Balouch
PLPeter Lewindon
Peter Lewindon
GLGuy Lampe
Guy Lampe
LELooi Ee
Looi Ee

16 July 2020 in Respirology Case Reports
Verified
Journal Article
Open access
PDF file
SBShreya Bhushan
Shreya Bhushan
VGVikas Goyal
Vikas Goyal
CWCameron Ward
Cameron Ward
MRMuddassir Rashid
Muddassir Rashid
NKNitin Kapur
Nitin Kapur
Tracheal and bronchial varices are rarely found in children. However, they have been described in adults with failing Fontan circuits or secondary to vascular pathology, such as portal and pulmonary hypertension. We report the presentation of haemoptysis and bronchial varices in a child, six years after a Fontan procedure for tricuspid atresia. She had tortuous mediastinal and transpleural arterial collaterals on computed tomography (CT) angiography and cardiac catheterization and subsequently underwent embolization of these collaterals. While the haemoptysis settled post embolization, the bronchial varices persisted on repeat bronchoscopy. She has since been clinically well with no further haemoptysis.

9 November 2022 in Journal of Hepatology
Verified
Journal Article
Open access
PDF file
SKShreya B. Kishore
Shreya B. Kishore
PLPeter Lewindon
Peter Lewindon
CNCharlton Noble
Charlton Noble
FBFariha Balouch
Fariha Balouch
We refer to the excellent, timely review by Lisman et al Lisman T. Caldwell S.H. Intagliata N.M. Haemostatic alterations and management of haemostasis in patients with cirrhosis. J Hepatol. 2022 Jun 1; 76 : 1291-1305 Google Scholar on “Hemostatic alterations and management of haemostasis in patients with cirrhosis”. Children with advanced liver disease awaiting liver transplantation or close to listing are at high risk of losing portal venous flow and portal thrombosis because of high hepatic resistance and a fragile, rebalanced hemostatic state. Loss of portal flow is reported to herald irreversible portal thrombosis, hepatocyte extinction with worsening hepatocyte function and risk of portal vein clot extension Iranpour P. Lall C. Houshyar R. Helmy M. Yang A. Choi J.I. Ward G. Goodwin S.C. Altered Doppler flow patterns in cirrhosis patients: an overview. J Ultrason. 2016 Jan; 35 : 3 Google Scholar . Treatment with anti-coagulation has been proposed for this complication but there is little published experience, especially in children. We report our experience from a statewide, paediatric liver transplant service after commencing a policy of frequent doppler ultrasound to monitor for and treat reversal of portal flow in children with end stage liver disease (Table 1).